It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are provided at the course site.

INSTRUCTORS

John Dopp, PharmD, MS, Associate Professor, School of Pharmacy, University of Wisconsin – Madison

Barry Gidal, PharmD, RPh, FAES,  Professor, School of Pharmacy, University of Wisconsin – Madison

Sara Hassan, BPharm, MS, PhD, School of Pharmacy, University of Wisconsin – Madison

Paul Hutson, PharmD, Professor, School of Pharmacy, University of Wisconsin – Madison

Angela Janis, MD, DFAPA, Psychiatrist, Mendota Mental Health Institute

Hunter Land, MS, Associate Director, Cannabinoid Research at Canopy Growth Corporaton

David Potter, JP, PhD, FRSB, FLS, Director of Botanical Research, GW Pharmaceuticals

Lucas Richert, PhD, Associate Professor, George Urdang Chair in the History of Pharmacy, School of Pharmacy, University of Wisconsin – Madison

Natalie Schmitz, MPA, PharmD, PhD, Assistant Professor, School of Pharmacy, University of Wisconsin – Madison

Cody Wenthur, PharmD, PhD, Assistant Professor, School of Pharmacy, University of Wisconsin – Madison